Join
Live feed
·
PRReleasevia Quantisnow
Cyclacel Pharmaceuticals Inc. logo

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB

ByQuantisnow·Wall Street's wire, on your screen.
CYCC· Cyclacel Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CYCC (Cyclacel Pharmaceuticals Inc.) and more on Quantisnow.